Feb 4 (Reuters) - Annovis Bio Inc ANVS.N:
ANNOVIS BIO, INC. ANNOUNCES CLOSING OF $21 MILLION PUBLIC OFFERING
ANNOVIS BIO INC - PROCEEDS TO FUND PHASE 3 STUDY OF BUNTANETAP FOR ALZHEIMER'S
Source text: ID:nGNX7SNjsY
Further company coverage: ANVS.N
((reuters.briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.